Purchase Order 75N92023P00257
Award Date 9/11/23
Potential Completion Date 9/11/24
Potential Value $144K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $130,000 purchase order to Illumina, Inc. for maintenance on the NovaSeq and MiSeq equipment used for sequencing services. The contract has a one-year period of performance from September 2021 through September 2022 and utilizes a firm fixed price contract type. Illumina will provide maintenance and support services on sequencing equipment located in San Diego, California...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute (HHS-NIH-NHLBI) awarded a $156,707 purchase order to Illumina, Inc. to renew an existing Illumina service contract. The one-year firm fixed price contract will provide ongoing services in support of the NHLBI's research programs from June 2021 through June 2022. Illumina will perform the work as the prime contractor in San Diego, California. No subcontractors or set aside...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $133,224.16 firm fixed price purchase order to Illumina, Inc. for a Silver Maintenance Support Plan. The contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has provided these products and related services to various federal agencies in the past, including the NIH, CDC, USDA, and VA. The award likely...
- <p>The National Heart Lung and Blood Institute issued a $4,480.82 delivery order to Illumina, Inc. on January 24, 2015, with ultimate completion by August 31, 2015.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with no set-aside designation.</p>
- <p>The National Heart Lung and Blood Institute issued a $19,715.78 delivery order to Illumina, Inc. on December 9, 2026, for Illumina reagents and consumables.</p> <p>Place of performance is San Diego, California. The order is firm fixed price with no set-aside applied. Ultimate completion date is December 9, 2019.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. valued at $190,561.89 on June 5, 2018, with final completion on June 4, 2019. The order is firm fixed-price with no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order covers Illumina service contract requirements, typical of the vendor's federal work providing genetic sequencing systems, reagents, and bioinformatics support to research institutions across civilian agencies.
- The National Institutes of Health's National Heart, Lung and Blood Institute awarded a $2.7 million firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. Under the contract, Illumina will provide Illumina reagents and consumables to support the Institute's research efforts over the course of one year. No major subcontractors or set aside designations were identified. The award draws from the NIH's broad portfolio investigating heart, lung, blood, and sleep...
- <p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on May 3, 2019, with a ceiling value of $54,938.64 for the addition of $4.80 in funds to line item 1.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- <p>The National Heart Lung and Blood Institute issued a $65,338.65 delivery order to Illumina, Inc. on February 19, 2019, for Illumina reagents and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price, with no set-aside applied.</p>
- <p>The National Heart Lung and Blood Institute issued a $18,909 delivery order to Illumina, Inc. on November 14, 2014, with an ultimate completion date of August 31, 2015. Place of performance is Bethesda, MD. The order is firm fixed price with no set-aside applied. The source does not identify the parent vehicle name or vehicle type under which this delivery order was issued.</p>